[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357627-105":59,"doc-detail-357627-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","genetic-analysis-of-primary-lung-interdigitating-dendritic-cell-sarcomas-original-article","Genetic analysis of primary lung interdigitating dendritic cell sarcomas - Original article","","Interdigitating dendritic cell sarcomas (IDCSs) are rare hematopoietic tumors whose genetic drivers remain unclear, limiting treatment options. Whole-exome sequencing paired with shallow whole-genome sequencing was used to study somatic mutations and copy-number alterations in nine primary lung IDCSs. Follicular, Langerhans, and inflammatory myofibroblastic tumors were excluded, and grade was stratified by Ki-67. High-grade cases showed more genome alteration and a heterogeneous CNV landscape with recurrent gains on chromosome 17, while actionable gene CNAs and mutations enabled identification of potential druggable biomarkers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetic-analysis-of-primary-lung-interdigitating-dendritic-cell-sarcomas-original-article/357627/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetic-analysis-of-primary-lung-interdigitating-dendritic-cell-sarcomas-original-article/357627.png","ImageObject",300,407,{"name":92,"@type":93},"Fans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study designed to determine in primary lung IDCSs?","Question",{"text":113,"@type":114},"The study evaluated whether genetic aberrations can be identified in IDCSs and whether these alterations are potentially druggable.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were IDCS tumor grades defined for analysis?",{"text":118,"@type":114},"Tumors were stratified using the Ki-67 score into low-grade (≤ 20%) and high-grade (> 20%) groups.",{"name":120,"@type":111,"acceptedAnswer":121},"What genetic differences were observed between high-grade and low-grade IDCSs?",{"text":122,"@type":114},"High-grade IDCSs showed a higher fraction of the genome altered by copy-number alterations (48.42% vs 18.15%) and tended to have higher tumor mutation burden.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},357627,1790185495,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Journal of Pathology  \nJ Pathol August 2026; 269: 387–398  \nPublished online 6 May 2026 in Wiley Online Library (wi[leyonlinelibrary.com](leyonlinelibrary.com) DOI: 10.1002/path.70066)[)](leyonlinelibrary.com) DOI: 10.1002/path.70066)[ DOI:](leyonlinelibrary.com) DOI: 10.1002/path.70066)[ 10.1002/path.70066](leyonlinelibrary.com) DOI: 10.1002/path.70066)  \nORIGINAL ARTICLE  \nGenetic analysis of primary lung interdigitating dendritic cell sarcomas  \nMikhail S Ermakov 1 , Juliana Faria Filipe2, Sylvia Eidenhammer 1 , German Ott3, Iris Halbwedl 1 , Karl Kashofer 1† and Helmut Popper 1 *†  \n1 Diagnostic & Research Institute of Pathology, Medical University Graz, Graz, Austria  \n2 Pathology Centre of Champalimaud Centre for the Unknown and Botton-Champalimaud Pancreatic Cancer Centre, Lisbon, Portugal  \n3 Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Robert-Bosch Clinics, Stuttgart, Germany  \n*Correspondence to: H Popper, Diagnostic & Research Institute of Pathology, Medical University Graz, Neue Stiftingtalstrasse 6, Graz, 8010, Austria. E-mail: [helmut.popper@medunigraz.at](helmut.popper@medunigraz.at)  \n†These authors contributed equally to this work.  \nAbstract  \nInterdigitating dendritic cell sarcomas (IDCSs) are rare tumors that commonly arise in the hematopoietic system and rarely outside. The genetic drivers of IDCS carcinogenesis are unknown; therefore, therapeutic options are limited. We investigated somatic gene mutations and copy-number alterations (CNAs) in nine IDCSs arising in the lung by wholeexome sequencing (WES) paired with shallow whole-genome sequencing (sWGS). Using a panel of immunohistochemical markers, follicular dendritic sarcomas and Langerhans cell sarcomas were excluded, and inﬂammatory myoﬁbroblastic tumors were excluded based on morphology. The Ki-67 score was used to stratify the tumors into low-grade (≤ 20%) and high-grade (> 20%) tumors. The main question addressed by the study was whether genetic aberrations can be identiﬁed in IDCSs and whether these are druggable. High-grade IDCSs showed a higher fraction of genome altered by CNA (48.42%) than low-grade IDCSs (18.15%) and tended to have greater tumor mutation burden (7.56 versus 0.88 mut/Mb; not signiﬁcant). Heterogeneous gains on chromosome 17 were characteristic of almost all IDCS cases (eight of nine cases, 89%), independent of grade. CNA in cancer-actionable genes was independent of clinicopathological characteristics and included ampliﬁcations in EGFR, MYC, MDM4, ERBB2, CCNE1, and BRAF and losses in MTAP, CDKN2A, CDKN2B, MLH1, and VHL, as well as homozygous losses in SMAD2/4, ATM, and TP53. Somatic gene mutations in cancer-related genes were identiﬁed in seven of nine IDCSs. No common driver mutations were identiﬁed. The heterogeneous genetic landscape suggests a mixed etiology of IDCS carcinogenesis and genomic instability in high-grade tumors. Distinct druggable biomarkers have been identiﬁed in almost all tumors, providing novel therapeutic options.  \n© 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great  \nBritain and Ireland.  \nKeywords: dendritic cell sarcoma; genetic aberrations; druggable drivers; lung tumors; next-generation sequencing; copy-number alterations; low and high-grade  \nReceived 7 February 2025; Revised 16 July 2025; Accepted 11 March 2026 No conﬂicts of interest were declared.  \nIntroduction  \nDendritic cells (DCs) are antigen-presenting cells of themononuclear phagocytic system that are important for innate and adaptive immune responses. DCs occur in all organs [1] . Different types of DC are discerned: Langerhans cells, classic DCs, immature DCs, interdigitating DCs, monocytoid DCs, follicular DCs, and plasmacytoid DCs [2–4] . Interdigitating dendritic cell sarcomas (IDCS) usually arise in younger patients compared to carcinomas, with a reported median age at diagnosis of 58 years and a male-to-female ratio of 1.65:1 [5] . Differe","cbCaitEmoTu2E0Pp","https://ap.wps.com/l/cbCaitEmoTu2E0Pp","pdf",58776148,12,"English","# Abstract\n# Introduction\n## Dendritic cells and tumor classification\n## Origin pathways and anatomical distribution\n## Challenges of lung IDCS diagnosis and known clinical associations","[{\"question\":\"What was the study designed to determine in primary lung IDCSs?\",\"answer\":\"The study evaluated whether genetic aberrations can be identified in IDCSs and whether these alterations are potentially druggable.\"},{\"question\":\"How were IDCS tumor grades defined for analysis?\",\"answer\":\"Tumors were stratified using the Ki-67 score into low-grade (≤ 20%) and high-grade (\\u003e 20%) groups.\"},{\"question\":\"What genetic differences were observed between high-grade and low-grade IDCSs?\",\"answer\":\"High-grade IDCSs showed a higher fraction of the genome altered by copy-number alterations (48.42% vs 18.15%) and tended to have higher tumor mutation burden.\"}]","Genetic analysis of primary lung interdigitating dendritic cell sarcomas - Original article | PDF",1790130896,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d14d52bb617355752872e50e48ba992.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/681cf8a1c0d2c6635ef3f5256fc40fea.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a337b56c476366383c805289b53e62a.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a628089f1cd34b705ca45278d500740b.webp",980,1385]